Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  HIV Infection

  Free Subscription


21.10.2019

4 AIDS Res Hum Retroviruses
3 Am J Epidemiol
1 Ann Intern Med
3 Antimicrob Agents Chemother
1 BMC Immunol
1 Br J Haematol
12 Clin Infect Dis
6 HIV Med
1 Int J Cancer
6 J Acquir Immune Defic Syndr
3 J Infect Dis
1 J Med Virol
6 J Virol
2 Lancet Glob Health
8 Lancet HIV
1 Lancet Respir Med
1 Nature
13 PLoS One
1 PLoS Pathog
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS Res Hum Retroviruses

  1. KALLIANPUR KJ, Walker M, Gerschenson M, Shikuma C, et al
    Systemic Mitochondrial Oxidative Phosphorylation Protein Levels Correlate with Neuroimaging Measures in Chronically HIV-Infected Individuals.
    AIDS Res Hum Retroviruses. 2019 Oct 16. doi: 10.1089/AID.2019.0240.
    PubMed     Text format     Abstract available

  2. TORRES MKS, Avelino MES, Irias SDF, Santos MB, et al
    Low prevalence of HIV-1 integrase resistance among antiretroviral-naive patients newly diagnosed with HIV-1 from Belem, Para, Amazon Region of Brazil.
    AIDS Res Hum Retroviruses. 2019 Oct 14. doi: 10.1089/AID.2019.0191.
    PubMed     Text format     Abstract available

  3. DUBE K, Eskaf S, Evans D, Sauceda J, et al
    The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy.
    AIDS Res Hum Retroviruses. 2019 Oct 14. doi: 10.1089/AID.2019.0175.
    PubMed     Text format     Abstract available

  4. LAU J, Smith MZ, Allan B, Martinez C, et al
    Community and provider Community and provider perspectives on Treatment Interruptions in the landscape of HIV cure focused studies.
    AIDS Res Hum Retroviruses. 2019 Oct 14. doi: 10.1089/AID.2019.0118.
    PubMed     Text format     Abstract available


    Am J Epidemiol

  5. WANG L, Moqueet N, Lambert G, Grace D, et al
    Population-Level Sexual Mixing By HIV Status and Pre-exposure Prophylaxis Use Among Men Who Have Sex with Men in Montreal, Canada: Implications for HIV Prevention.
    Am J Epidemiol. 2019 Oct 15. pii: 5587085. doi: 10.1093.
    PubMed     Text format     Abstract available

  6. ALTHOFF KN, Chandran A, Zhang J, Arevalo WM, et al
    LIFE EXPECTANCY DISPARITIES AMONG ADULTS WITH HIV IN THE UNITED STATES AND CANADA: THE IMPACT OF A REDUCTION IN DRUG- AND ALCOHOL-RELATED DEATHS USING THE LIVES SAVED SIMULATION (LISSO) MODEL.
    Am J Epidemiol. 2019 Oct 11. pii: 5583226. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. MACINSKI SE, Gunn JKL, Goyal M, Neighbors C, et al
    Validation of an Optimized Algorithm to Identify Persons Living with Diagnosed HIV from the New York State Medicaid Data, 2006-2014.
    Am J Epidemiol. 2019 Oct 15. pii: 5587083. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Intern Med

  8. SINGH M
    Guideline: USPSTF recommends preexposure prophylaxis with antiretroviral therapy for persons at high risk for HIV.
    Ann Intern Med. 2019;171:JC38.
    PubMed     Text format    


    Antimicrob Agents Chemother

  9. SALADINI F, Giannini A, Boccuto A, Dragoni F, et al
    Comparable in vitro activity of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01717.
    PubMed     Text format     Abstract available

  10. FISCHER K, Nguyen K, LiWang PJ
    Griffithsin retains anti-HIV-1 potency with changes in gp120 glycosylation and complements broadly neutralizing antibodies PGT121 and PGT126.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01084.
    PubMed     Text format     Abstract available

  11. DEVANATHAN AS, Pirone JR, Akkina R, Remling-Mulder L, et al
    Antiretroviral penetration across three preclinical animal models and humans in eight putative HIV viral reservoirs.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01639.
    PubMed     Text format     Abstract available


    BMC Immunol

  12. DESALEGN G, Tsegaye A, Gebreegziabiher D, Aseffa A, et al
    Enhanced IFN-gamma, but not IL-2, response to Mycobacterium tuberculosis antigens in HIV/latent TB co-infected patients on long-term HAART.
    BMC Immunol. 2019;20:35.
    PubMed     Text format     Abstract available


    Br J Haematol

  13. NYLAND SB, Feith DJ, Poss M, Olson TL, et al
    Retroviral sero-reactivity in LGL leukaemia patients and family members.
    Br J Haematol. 2019 Oct 14. doi: 10.1111/bjh.16223.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  14. LE GUILLOU A, Pugliese P, Raffi F, Cabie A, et al
    Reaching the Second and Third Joint United Nations Programme on HIV/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary Human Immunodeficiency Virus (HIV) Infection and in Recent HIV Infections in a Large French Nationwide HIV Coho
    Clin Infect Dis. 2019 Aug 17. pii: 5550908. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. SAX PE, Erlandson KM, Lake JE, McComsey GA, et al
    Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials.
    Clin Infect Dis. 2019 Oct 14. pii: 5586728. doi: 10.1093.
    PubMed     Text format     Abstract available

  16. LEDDY AM, Sheira LA, Tamraz B, Sykes C, et al
    Food insecurity is associated with lower levels of antiretroviral drug concentrations in hair among a cohort of women living with HIV in the United States.
    Clin Infect Dis. 2019 Oct 14. pii: 5586763. doi: 10.1093/cid/ciz1007.
    PubMed     Text format     Abstract available

  17. SHIN SS, Satyanarayana VA, Ekstrand ML, Carpenter CL, et al
    The effect of community-based nutritional interventions on children of women living with HIV in rural India: A 2 x 2 factorial intervention trial.
    Clin Infect Dis. 2019 Oct 14. pii: 5586765. doi: 10.1093/cid/ciz1009.
    PubMed     Text format     Abstract available

  18. BURNHAM JP, Geng E, Venkatram C, Colditz GA, et al
    Putting the Dissemination and Implementation in Infectious Diseases.
    Clin Infect Dis. 2019 Oct 14. pii: 5586766. doi: 10.1093/cid/ciz1011.
    PubMed     Text format     Abstract available

  19. OFOTOKUN I, Collins LF, Titanji K, Foster A, et al
    Antiretroviral Therapy-induced Bone Loss is Durably Suppressed by a Single Dose of Zoledronic Acid in Treatment-naive Persons with HIV Infection: a Phase IIB Trial.
    Clin Infect Dis. 2019 Oct 17. pii: 5588958. doi: 10.1093/cid/ciz1027.
    PubMed     Text format     Abstract available

  20. RAMENDRA R, Isnard S, Lin J, Fombuena B, et al
    CMV seropositivity is associated with increased microbial translocation in people living with HIV and uninfected controls.
    Clin Infect Dis. 2019 Oct 14. pii: 5586739. doi: 10.1093/cid/ciz1001.
    PubMed     Text format     Abstract available

  21. FOJO AT, Dowdy DW
    Ending the HIV Epidemic: Towards an Evidence-Based Approach.
    Clin Infect Dis. 2019 Oct 14. pii: 5586985. doi: 10.1093/cid/ciz1018.
    PubMed     Text format    

  22. NOSYK B, Zang X, Krebs E, Min JE, et al
    Ending the epidemic in America will not happen if the status quo continues: modeled projections for HIV incidence in 6 US cities.
    Clin Infect Dis. 2019 Oct 14. pii: 5587001. doi: 10.1093/cid/ciz1015.
    PubMed     Text format     Abstract available

  23. CHOW DC, Bernas MA, Gangcuangco LM, Huynh J, et al
    Frailty is associated with insulin resistance in chronic HIV.
    Clin Infect Dis. 2019 Oct 15. pii: 5587091. doi: 10.1093/cid/ciz1017.
    PubMed     Text format    

  24. NEWMAN KL, Newman GS, Cybulski RJ, Fang FC, et al
    Gastroenteritis in Men Who Have Sex With Men in Seattle, Washington, 2017-2018.
    Clin Infect Dis. 2019 Oct 17. pii: 5588835. doi: 10.1093.
    PubMed     Text format     Abstract available

  25. NAIDOO K, Hassan-Moosa R, Mlotshwa P, Yende-Zuma N, et al
    High Rates of Drug-induced Liver Injury in People Living With HIV Coinfected With Tuberculosis (TB) Irrespective of Antiretroviral Therapy Timing During Antituberculosis Treatment: Results From the Starting Antiretroviral Therapy at Three Points in TB
    Clin Infect Dis. 2019 Oct 17. pii: 5589114. doi: 10.1093.
    PubMed     Text format     Abstract available


    HIV Med

  26. ORBAEK M, Thorsteinsson K, Moseholm Larsen E, Katzenstein TL, et al
    Risk factors during pregnancy and birth-related complications in HIV-positive versus HIV-negative women in Denmark, 2002-2014.
    HIV Med. 2019 Oct 11. doi: 10.1111/hiv.12798.
    PubMed     Text format     Abstract available

  27. RIPAMONTI E, Clerici M
    The association of memory disorders and chronic HIV disease in the antiretroviral therapy era: a systematic literature review.
    HIV Med. 2019 Oct 11. doi: 10.1111/hiv.12793.
    PubMed     Text format     Abstract available

  28. SERRAO A, Santoro C, Foa R, Chistolini A, et al
    Use of edoxaban for the treatment of venous thromboembolism in HIV-infected patients.
    HIV Med. 2019 Oct 16. doi: 10.1111/hiv.12803.
    PubMed     Text format    

  29. FRANCIS-MORRIS A, Mackie NE, Eliahoo J, Ramzan F, et al
    Compromised CD4:CD8 ratio recovery in people living with HIV aged over 50 years: an observational study.
    HIV Med. 2019 Oct 16. doi: 10.1111/hiv.12800.
    PubMed     Text format     Abstract available

  30. INCIARTE A, Leal L, Masfarre L, Gonzalez E, et al
    Post-exposure prophylaxis for HIV infection in sexual assault victims.
    HIV Med. 2019 Oct 11. doi: 10.1111/hiv.12797.
    PubMed     Text format     Abstract available

  31. WILKINSON A, Quinn B, Draper B, White S, et al
    Prevalence of daily tobacco smoking participation among HIV-positive and HIV-negative Australian gay, bisexual and other men who have sex with men.
    HIV Med. 2019 Oct 11. doi: 10.1111/hiv.12802.
    PubMed     Text format    


    Int J Cancer

  32. SHMAKOVA A, Germini D, Vassetzky Y
    HIV-1, HAART and cancer: a complex relationship.
    Int J Cancer. 2019 Oct 11. doi: 10.1002/ijc.32730.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  33. SALVATORE P, Johnson K, Vojnov L, Doherty M, et al
    Clinical Consequences of Using an Indeterminate Range for Early Infant Diagnosis of HIV: A Decision Model.
    J Acquir Immune Defic Syndr. 2019;82:287-296.
    PubMed     Text format     Abstract available

  34. LUO R, Boeras D, Broyles LN, Fong Y, et al
    Use of an Indeterminate Range in HIV Early Infant Diagnosis: A Systematic Review and Meta-Analysis.
    J Acquir Immune Defic Syndr. 2019;82:281-286.
    PubMed     Text format     Abstract available

  35. DIRAJLAL-FARGO S, Yu J, Kulkarni M, Sattar A, et al
    Brief Report: Zinc Supplementation and Inflammation in Treated HIV.
    J Acquir Immune Defic Syndr. 2019;82:275-280.
    PubMed     Text format     Abstract available

  36. LODI S, Gunthard HF, Gill J, Phillips AN, et al
    Effectiveness of Transmitted Drug Resistance Testing Before Initiation of Antiretroviral Therapy in HIV-Positive Individuals.
    J Acquir Immune Defic Syndr. 2019;82:314-320.
    PubMed     Text format     Abstract available

  37. KITYO C, Hagins D, Koenig E, Avihingsanon A, et al
    Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial.
    J Acquir Immune Defic Syndr. 2019;82:321-328.
    PubMed     Text format     Abstract available

  38. GILBERT HN, Wyatt MA, Pisarski EE, Muwonge TR, et al
    PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples.
    J Acquir Immune Defic Syndr. 2019;82:265-274.
    PubMed     Text format     Abstract available


    J Infect Dis

  39. CHIHOTA BV, Wandeler G, Chilengi R, Mulenga L, et al
    High Rates of Hepatitis B Virus (HBV) Functional Cure Among Human Immunodeficiency Virus-HBV Coinfected Patients on Antiretroviral Therapy in Zambia.
    J Infect Dis. 2019 Oct 15. pii: 5581876. doi: 10.1093.
    PubMed     Text format     Abstract available

  40. WOOD MP, Wood LF, Templeton M, Fisher B, et al
    Transient Immune Activation in BCG-Vaccinated Infant Rhesus Macaques Is Not Sufficient to Influence Oral Simian Immunodeficiency Virus Infection.
    J Infect Dis. 2019 Oct 12. pii: 5586557. doi: 10.1093.
    PubMed     Text format     Abstract available

  41. KILAPANDAL VENKATRAMAN SM, Sivanandham R, Pandrea I, Apetrei C, et al
    BCG Vaccination and Mother-to-Infant Transmission of HIV.
    J Infect Dis. 2019 Oct 12. pii: 5586559. doi: 10.1093.
    PubMed     Text format    


    J Med Virol

  42. REN L, Wang B, Miao Z, Liu P, et al
    A Correlation Analysis of HHV Infection and Its Predictive Factors in An HIV-seropositive Population in Yunnan, China.
    J Med Virol. 2019 Oct 17. doi: 10.1002/jmv.25609.
    PubMed     Text format     Abstract available


    J Virol

  43. VAN DORSTEN RT, Lambson BE, Wibmer CK, Weinberg MS, et al
    Neutralization breadth and potency of single-chain variable fragments derived from broadly neutralizing antibodies targeting multiple epitopes on the HIV-1 envelope.
    J Virol. 2019 Oct 16. pii: JVI.01533-19. doi: 10.1128/JVI.01533.
    PubMed     Text format     Abstract available

  44. RINGE RP, Colin P, Torres JL, Yasmeen A, et al
    SOS and IP modifications predominantly affect the yield but not other properties of SOSIP.664 HIV-1 Env glycoprotein trimers.
    J Virol. 2019 Oct 16. pii: JVI.01521-19. doi: 10.1128/JVI.01521.
    PubMed     Text format     Abstract available

  45. ZHU Y, Ding X, Yu D, Chong H, et al
    The Tryptophan-Rich Motif of HIV-1 Gp41 Can Interact with the N-Terminal Deep Pocket Site: New Insights into the Structure and Function of Gp41 and Its Inhibitors.
    J Virol. 2019 Oct 16. pii: JVI.01358-19. doi: 10.1128/JVI.01358.
    PubMed     Text format     Abstract available

  46. MAVIGNER M, Zanoni M, Tharp GK, Habib J, et al
    Pharmacological modulation of the Wnt/beta-catenin pathway inhibits proliferation and promotes differentiation of long-lived memory CD4(+) T-cells in ART-suppressed SIV-infected macaques.
    J Virol. 2019 Oct 16. pii: JVI.01094-19. doi: 10.1128/JVI.01094.
    PubMed     Text format     Abstract available

  47. KIBLER KV, Asbach B, Perdiguero B, Garcia-Arriaza J, et al
    Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC".
    J Virol. 2019;93.
    PubMed     Text format    

  48. TEDBURY PR, Novikova M, Alfadhli A, Hikichi Y, et al
    HIV-1 matrix trimerization-impaired mutants are rescued by matrix substitutions that enhance envelope glycoprotein incorporation.
    J Virol. 2019 Oct 16. pii: JVI.01526-19. doi: 10.1128/JVI.01526.
    PubMed     Text format     Abstract available


    Lancet Glob Health

  49. BIRDTHISTLE I, Tanton C, Tomita A, de Graaf K, et al
    Recent levels and trends in HIV incidence rates among adolescent girls and young women in ten high-prevalence African countries: a systematic review and meta-analysis.
    Lancet Glob Health. 2019;7:e1521-e1540.
    PubMed     Text format     Abstract available

  50. KARIM SSA, Baxter C
    HIV incidence rates in adolescent girls and young women in sub-Saharan Africa.
    Lancet Glob Health. 2019;7:e1470-e1471.
    PubMed     Text format    


    Lancet HIV

  51. STANNAH J, Dale E, Elmes J, Staunton R, et al
    HIV testing and engagement with the HIV treatment cascade among men who have sex with men in Africa: a systematic review and meta-analysis.
    Lancet HIV. 2019 Oct 7. pii: S2352-3018(19)30239.
    PubMed     Text format     Abstract available

  52. AUDSLEY J, Sasadeusz J, Lewin SR
    Tesamorelin, liver fat, and NAFLD in the setting of HIV.
    Lancet HIV. 2019 Oct 11. pii: S2352-3018(19)30331.
    PubMed     Text format    

  53. BIGNA JJ, Nansseu JR
    Men who have sex with men: a key population in Africa.
    Lancet HIV. 2019 Oct 7. pii: S2352-3018(19)30265.
    PubMed     Text format    

  54. COHEN K, Orrell CJ
    Transition to third-line ART in resource-limited settings.
    Lancet HIV. 2019 Oct 7. pii: S2352-3018(19)30324.
    PubMed     Text format    

  55. EHOLIE SP, Moh R, Benalycherif A, Gabillard D, et al
    Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study.
    Lancet HIV. 2019 Oct 7. pii: S2352-3018(19)30228.
    PubMed     Text format     Abstract available

  56. FELBER BK, Pavlakis GN
    HIV vaccine: better to start together?
    Lancet HIV. 2019 Oct 7. pii: S2352-3018(19)30323.
    PubMed     Text format    

  57. PANTALEO G, Janes H, Karuna S, Grant S, et al
    Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial.
    Lancet HIV. 2019 Oct 7. pii: S2352-3018(19)30262.
    PubMed     Text format     Abstract available

  58. STANLEY TL, Fourman LT, Feldpausch MN, Purdy J, et al
    Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial.
    Lancet HIV. 2019 Oct 11. pii: S2352-3018(19)30338.
    PubMed     Text format     Abstract available


    Lancet Respir Med

  59. CYPEL M, Feld JJ, Galasso M, Pinto Ribeiro RV, et al
    Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
    Lancet Respir Med. 2019 Oct 9. pii: S2213-2600(19)30268.
    PubMed     Text format     Abstract available


    Nature

  60. BURSTEIN R, Henry NJ, Collison ML, Marczak LB, et al
    Mapping 123 million neonatal, infant and child deaths between 2000 and 2017.
    Nature. 2019;574:353-358.
    PubMed     Text format     Abstract available


    PLoS One

  61. TARAMASSO L, Di Biagio A, Riccardi N, Briano F, et al
    Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: Different effects in patients with or without baseline hypercholesterolemia.
    PLoS One. 2019;14:e0223181.
    PubMed     Text format     Abstract available

  62. SIMEON K, Sharma M, Dorward J, Naidoo J, et al
    Comparative cost analysis of point-of-care versus laboratory-based testing to initiate and monitor HIV treatment in South Africa.
    PLoS One. 2019;14:e0223669.
    PubMed     Text format     Abstract available

  63. MALELE KOLISA Y, Yengopal V, Shumba K, Igumbor J, et al
    The burden of oral conditions among adolescents living with HIV at a clinic in Johannesburg, South Africa.
    PLoS One. 2019;14:e0222568.
    PubMed     Text format     Abstract available

  64. BRODY C, Chhoun P, Tuot S, Swendeman D, et al
    Childhood conditions, pathways to entertainment work and current practices of female entertainment workers in Cambodia: Baseline findings from the Mobile Link trial.
    PLoS One. 2019;14:e0216578.
    PubMed     Text format     Abstract available

  65. IGUMBOR JO, Ouma J, Otwombe K, Musenge E, et al
    Effect of a Mentor Mother Programme on retention of mother-baby pairs in HIV care: A secondary analysis of programme data in Uganda.
    PLoS One. 2019;14:e0223332.
    PubMed     Text format     Abstract available

  66. DI CRISTANZIANO V, D Alfonso R, Berrilli F, Sarfo FS, et al
    Correction: Lower prevalence of Blastocystis sp. infections in HIV positive compared to HIV negative adults in Ghana.
    PLoS One. 2019;14:e0224000.
    PubMed     Text format     Abstract available


  67. Correction: Factors associated with hospitalization and death among TB/HIV co-infected persons in Porto Alegre, Brazil.
    PLoS One. 2019;14:e0224230.
    PubMed     Text format     Abstract available

  68. FOCA E, Magro P, Guaraldi G, Riva A, et al
    Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort.
    PLoS One. 2019;14:e0222225.
    PubMed     Text format     Abstract available

  69. FANJUL F, Campins A, Asensio J, Samperiz G, et al
    Interatrial blocks prevalence and risk factors for human immunodeficiency virus-infected persons.
    PLoS One. 2019;14:e0223777.
    PubMed     Text format     Abstract available

  70. JERENE D, Abebe W, Taye K, Ruff A, et al
    Adolescents living with HIV are at higher risk of death and loss to follow up from care: Analysis of cohort data from eight health facilities in Ethiopia.
    PLoS One. 2019;14:e0223655.
    PubMed     Text format     Abstract available

  71. SIKOMBE K, Hantuba C, Musukuma K, Sharma A, et al
    Accurate dried blood spots collection in the community using non-medically trained personnel could support scaling up routine viral load testing in resource limited settings.
    PLoS One. 2019;14:e0223573.
    PubMed     Text format     Abstract available

  72. VOJTECH L, Zhang M, Dave V, Levy C, et al
    Extracellular vesicles in human semen modulate antigen-presenting cell function and decrease downstream antiviral T cell responses.
    PLoS One. 2019;14:e0223901.
    PubMed     Text format     Abstract available

  73. DICKER I, Zhang S, Ray N, Beno BR, et al
    Resistance profile of the HIV-1 maturation inhibitor GSK3532795 in vitro and in a clinical study.
    PLoS One. 2019;14:e0224076.
    PubMed     Text format     Abstract available


    PLoS Pathog

  74. WONDERLICH ER, Subramanian K, Cox B, Wiegand A, et al
    Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals.
    PLoS Pathog. 2019;15:e1008074.
    PubMed     Text format     Abstract available


    Vaccine

  75. BERNSTEIN DI, Morello CS, Cardin RD, Bravo FJ, et al
    A vaccine containing highly purified virus particles in adjuvant provides high level protection against genital infection and disease in guinea pigs challenged intravaginally with homologous and heterologous strains of herpes simplex virus type 2.
    Vaccine. 2019 Oct 11. pii: S0264-410X(19)31332.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: